Position in BRKR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$286,394,880
+$163,201,980 QoQ
Shares Held
4,643,000
+41.2% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
4.56%
of 13F equity value
Holder Rank
#7
of 425 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BRKR Over Time
Shares Held
Position Value (USD)
Derivatives in BRKR
reported options exposure · as of Jun 30, 2026CallValue
$30,090,000
CallShares
500,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Sculptor Capital LP holds $541,422,630 across 5 Medical Devices names. BRKR ranks #1 (52.9% of the industry book) .
All Filings in BRKR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 BRKRP | $8,062,380 | 18,000 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $30,090,000 | 500,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $278,332,500 | 4,625,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 BRKRP | $5,080,500 | 18,000 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $118,112,400 | 3,270,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 BRKRP | $3,660,000 | 10,000 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $141,330,000 | 3,000,000 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 BRKRP | $10,207,177 | 37,554 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $99,900,284 | 3,074,801 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $126,681,801 | 3,074,801 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $108,458,802 | 2,598,438 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $100,475,559 | 1,714,015 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,265,380 | 293,446 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||